Sequential intravesical gemcitabine and docetaxel for treatment-naïve and previously treated intermediate-risk nonmuscle invasive bladder cancer

Overview of attention for article published in Urologic Oncology, July 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

blogs: 1 blog
twitter: 7 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 10,969 followers.

Sequential intravesical gemcitabine and docetaxel for treatment-naïve and previously treated intermediate-risk nonmuscle invasive bladder cancer https://t.co/KlEbRHHXt1

RT @VigneshPackiam: Continued great work by super 🌟 @IanMcelree Gem/Doce effective in treatment naive (79% 2 year RFS) and previously tre…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.